Understanding Phase 2 (Fat-Burning Focus) for Weight Loss: What the Research Says

Understanding Phase 2 (Fat-Burning Focus) for Weight Loss: What the Research Says Welcome to CFP Weight Loss. I'm Russell Clark, Nurse Practitioner. Today, we're exploring Understanding Phase 2 (Fat-Burning Focus) for Weight Loss: What the Research Says. ... Take a breath, settle in, and let's walk through this together — clearly, calmly, and based on what the evidence actually shows. ... We'll touch on Phase 2 Weight Loss, Tirzepatide Protocol, GLP-1 GIP Research — especially as they apply to real people over forty. ... Phase 2 of the CFP Weight Loss Protocol . marks the aggressive fat-burning window where metabolic transformation accelerates. Spanning roughly 40 days within a broader 70-day cycle, this phase shifts the body from repair to rapid fat utilization through strategic low-dose tirzepatide, a lectin-free low-carb framework, and targeted anti-inflammatory nutrition. Unlike traditional CICO approaches that focus solely on calories, Phase 2 prioritizes hormonal optimization, mitochondrial efficiency , and restoring leptin sensitivity for sustainable results. ... Research increasingly validates this hormone-centric model. Dual incretin therapies targeting both GLP-1 and GIP pathways demonstrate superior fat loss compared to GLP-1 agonists alone. Listen at CFP Weight Loss — clinical guide with Russell Clark, FNP-C. Read more: https://blog.cfpweightloss.com/understanding-phase-2-fat-burning-focus-for-weight-loss-what-the-research-says